Literature DB >> 30890505

[Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].

Ruicheng Li1, Zhaowei Gao1, Ke Dong1, Huiping Wang1, Huizhong Zhang1.   

Abstract

OBJECTIVE: To study the clinical value of detecting carcinoembryonic antigen levels in pleural effusion (PCEA) and serum (SCEA) and their ratio (P/S) in the differential diagnosis of pleural effusions resulting from tuberculosis and lung cancer.
METHODS: This retrospectively study was conducted among 82 patients with pleural effusion caused by pulmonary tuberculous (TB; control group) and 120 patients with pleural effusion resulting from lung cancer in our hospital between April, 2016 and March, 2018. PCEA, SCEA and P/S were compared between the two groups and among the subgroups of lung cancer patients with squamous cell carcinoma (SqCa), adenocarcinoma (ACA), small cell carcinoma (SCLC). The receiveroperating characteristic curve (ROC) analysis was used to confirm the optimal critical value to evaluate the diagnostic efficiency of different combinations of PCEA, SCEA and P/S.
RESULTS: PCEA, SCEA and P/S were significantly higher in the overall cancer patients and in all the 3 subgroups of cancer patients than in the patients with TB (P < 0.05). The areas under the ROC curve of PCEA, SCEA and P/S were 0.925, 0.866 and 0.796, respectively; PCEA had the highest diagnostic value, whose diagnostic sensitivity, specificity, accurate rate, and diagnostic threshold were 83.33%, 96.34, 88.61%, and 3.26 ng/ml, respectively; SCEA had the lowest diagnostic performance; the diagnostic performance of P/S was between that of SCEA and PCEA, but its combination with SCEA greatly improved the diagnostic performance and reduced the rates of misdiagnosis and missed diagnosis. Parallel tests showed that the 3 indexes combined had significantly higher diagnostic sensitivity than each or any two of the single indexes (P < 0.05), but the diagnostic specificity did not differ significantly. The area under the ROC curve of combined detections of the 3 indexes was 0.941 for diagnosis of lung cancer-related pleural effusion, higher than those of any other combinations of the indexes.
CONCLUSIONS: The combined detection of PCEA, SCEA and P/S has a high sensitivity for diagnosis of lung cancer-related pleural effusion and provides important information for rapid and accurate diagnosis of suspected cases.

Entities:  

Keywords:  carcinoembryonic antigen; clinical diagnosis; lung cancer; pleural effusion; tuberculous pleurisy

Mesh:

Substances:

Year:  2019        PMID: 30890505      PMCID: PMC6765630          DOI: 10.12122/j.issn.1673-4254.2019.02.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  24 in total

Review 1.  Diagnostic molecular biomarkers for malignant pleural effusions.

Authors:  Krishna B Sriram; Vandana Relan; Belinda E Clarke; Edwina E Duhig; Ian A Yang; Rayleen V Bowman; Y C Gary Lee; Kwun M Fong
Journal:  Future Oncol       Date:  2011-06       Impact factor: 3.404

2.  Exploring medical diagnostic performance using interactive, multi-parameter sourced receiver operating characteristic scatter plots.

Authors:  Hyatt E Moore; Olivier Andlauer; Noah Simon; Emmanuel Mignot
Journal:  Comput Biol Med       Date:  2014-02-03       Impact factor: 4.589

3.  Pleural adenosine deaminase cut-off value for the diagnosis of tuberculous pleural effusion using the Diazyme assay.

Authors:  A Servonnet; C Frederic; F Fargeau; H Delacour
Journal:  Hong Kong Med J       Date:  2018-04       Impact factor: 2.227

4.  CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.

Authors:  Luis Hernández; Antonia Espasa; Cleofé Fernández; Alfredo Candela; Concepción Martín; Santiago Romero
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

5.  Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.

Authors:  Jeong-Seon Ryu; Hyo Jin Ryu; Si-Nae Lee; Azra Memon; Seul-Ki Lee; Hae-Seong Nam; Hyun-Jung Kim; Kyung-Hee Lee; Jae-Hwa Cho; Seung-Sik Hwang
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

6.  Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone?

Authors:  S A Sahn; J T Huggins; M E San José; J M Álvarez-Dobaño; L Valdés
Journal:  Int J Tuberc Lung Dis       Date:  2013-06       Impact factor: 2.373

7.  Time sensitivity-corrected retention index: an enhanced metabolic index from 18F-FDG PET to differentiate between benign and malignant pulmonary nodules.

Authors:  Ching-yee O Wong; Zaid Al-faham; Prashant Jolepalem; William W Wong; Joseph Thie
Journal:  Nucl Med Commun       Date:  2014-12       Impact factor: 1.690

8.  Carcinoembryonic antigen-positive pleural effusion in early stage non-small cell lung cancer without pleural infiltration.

Authors:  Njanja Enz; Fernando Fragoso; Alexander Gamrekeli; Frank Lippek; Wolfgang Jungraithmayr
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Amiodarone-induced loculated pleural effusion without pulmonary parenchymal involvement: A case report and literature review.

Authors:  Amer Hawatmeh; Mohammad Thawabi; Ashraf Jmeian; Hamid Shaaban; Fayez Shamoon
Journal:  J Nat Sci Biol Med       Date:  2017 Jan-Jun

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  1 in total

1.  Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.

Authors:  Tiantian Zhang; Wei Liu; Li Li; Zou Jue; Chunhua Xu
Journal:  BMC Pulm Med       Date:  2022-08-10       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.